{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:48:33Z","timestamp":1785422913893,"version":"3.56.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T00:00:00Z","timestamp":1488412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0172512","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T13:55:37Z","timestamp":1488462937000},"page":"e0172512","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses"],"prefix":"10.1371","volume":"12","author":[{"given":"Deborah","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Fryzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,3,2]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1155\/2011\/493056","article-title":"A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice","volume":"18","author":"BA Paes","year":"2011","journal-title":"Can Respir J"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/INF.0b013e31822e68e6","article-title":"Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997\u20132006","volume":"31","author":"LJ Stockman","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1542\/peds.2013-0303","article-title":"Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age","volume":"132","author":"CB Hall","year":"2013","journal-title":"Pediatrics"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/INF.0b013e3182184ae7","article-title":"Epidemiology and prevention of respiratory syncytial virus infections among infants and young children","volume":"30","author":"GF Langley","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"ref5","article-title":"Respiratory tract infection and risk of hospitalization in children with congenital heart defects during season and off-season: a Swedish national study","author":"E Granbom","year":"2016","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in medicaid","volume":"137","author":"TG Boyce","year":"2000","journal-title":"J Pediatr"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s002460010103","article-title":"Respiratory syncytial virus in patients with congenital heart disease: a contemporary look at epidemiology and success of preoperative screening","volume":"21","author":"CA Altman","year":"2000","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3345\/kjp.2011.54.5.192","article-title":"Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey","volume":"54","author":"JW Jung","year":"2011","journal-title":"Korean J Pediatr"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcrc.2011.12.001","article-title":"Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis","volume":"27","author":"KL Hon","year":"2012","journal-title":"J Crit Care"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/00003246-199210000-00008","article-title":"Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience","volume":"20","author":"FW Moler","year":"1992","journal-title":"Crit Care Med"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00431-007-0426-y","article-title":"Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database","volume":"166","author":"A Simon","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"TF Feltes","year":"2003","journal-title":"J Pediatr"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/ppul.23102","article-title":"Efficacy of palivizumab prophylaxis among infants with congenital heart disease: A case control study","volume":"50","author":"A Ozyurt","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1542\/peds.112.6.1442","article-title":"Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections","volume":"112","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1542\/peds.2014-1665","article-title":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"134","year":"2014","journal-title":"Pediatrics"},{"key":"ref17","unstructured":"Healthcare Cost and Utilization Project (HCUP). National Inpatient Sample (NIS) Database 2013 [cited 2015 December]. Available from: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp<\/ext-link>."},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.athoracsur.2008.10.032","article-title":"Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards","volume":"87","author":"KF Welke","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"ref19","unstructured":"Agency for Healthcare Research and Quality. Pediatric Quality Indicators #7: Technical Specifications. Pediatric Heart Surgery Volume [version 4.4] 2012 [cited 2016 April]. Available from: http:\/\/qualityindicators.ahrq.gov\/downloads\/modules\/pdi\/v44\/techspecs\/pdi%2007%20pediatric%20heart%20surgery%20volume.pdf<\/ext-link>."},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.jp.7211382","article-title":"Validity of hospital discharge data for identifying infants with cardiac defects","volume":"25","author":"BK Frohnert","year":"2005","journal-title":"J Perinatol"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0009922814546040","article-title":"The Underrecognized Burden of Respiratory Syncytial Virus Among Infants Presenting to US Emergency Departments","volume":"54","author":"D Makari","year":"2015","journal-title":"Clin Pediatr (Phila)"},{"key":"ref22","unstructured":"Bureau of Labor Statistics United States Department of Labor. CPI (Consumer Price Index) Inflation Calculator 2015 [cited 2015 May 22]. Available from: http:\/\/www.bls.gov\/data\/inflation_calculator.htm<\/ext-link>."},{"key":"ref23","article-title":"Red Book: Report of the Committee on Infectious Diseases","author":"G Peter","year":"1997"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1542\/peds.2006-2223","article-title":"Diagnosis and management of bronchiolitis","volume":"118","year":"2006","journal-title":"Pediatrics"},{"key":"ref25","article-title":"Red Book: Report of the Committee on Infectious Disease","author":"LK Pickering","year":"2012"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1542\/peds.2009-3221","article-title":"Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis","volume":"126","author":"CA Panozzo","year":"2010","journal-title":"Pediatrics"},{"key":"ref27","article-title":"Comparing First- and Second-Year Palivizumab Prophylaxis in Patients with Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005\u20132015)","author":"A Li","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"ref28","first-page":"199 e1","article-title":"Update of recommendations on the use of palivizumab as prophylaxis in RSV infections","volume":"82","author":"Aloy J Figueras","year":"2015","journal-title":"An Pediatr (Barc)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40267-015-0275-0","article-title":"Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The Netherlands","volume":"32","author":"B Whelan","year":"2016","journal-title":"Drugs Ther Perspect"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1442-200X.2006.02179.x","article-title":"Guidelines for the use of palivizumab in infants and young children with congenital heart disease","volume":"48","author":"M Nakazawa","year":"2006","journal-title":"Pediatr Int"},{"key":"ref31","article-title":"Guideline for the prevention of serious diseases by Respiratory Syncytial Virus (RSV) in children at risk","author":"J Forster","year":"2012"},{"key":"ref32","unstructured":"Public Health England. Immunisation against infectious disease: Respiratory syncytial virus: the green book, chapter 27a (updated 4 September 2015) 2013 [cited 2016 June 7]. Available from: https:\/\/www.gov.uk\/government\/publications\/respiratory-syncytial-virus-the-green-book-chapter-27a<\/ext-link>."},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/apa.12658","article-title":"Evaluating national guidelines for the prophylactic treatment of respiratory syncytial virus in children with congenital heart disease","volume":"103","author":"E Granbom","year":"2014","journal-title":"Acta Paediatr"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/pch\/20.6.321","article-title":"Preventing hospitalizations for respiratory syncytial virus infection","volume":"20","author":"JL Robinson","year":"2015","journal-title":"Paediatr Child Health"},{"key":"ref35","article-title":"Recommendations on prophylaxis respiratory infection by viruses syncytial (RSV) with palivizumab","author":"L Bollani","year":"2015"},{"issue":"Suppl 2","key":"ref36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1017\/S1047951108002515","article-title":"The importance of nomenclature for congenital cardiac disease: implications for research and evaluation","volume":"18","author":"MJ Strickland","year":"2008","journal-title":"Cardiol Young"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/chd.12293","article-title":"Fractures Related to Metabolic Bone Disease in Children with Congenital Heart Disease","volume":"11","author":"HH Cheng","year":"2016","journal-title":"Congenit Heart Dis"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1651-2227.2010.02029.x","article-title":"Chronic conditions in children increase the risk for physical abuse\u2014but vary with socio-economic circumstances","volume":"100","author":"B Svensson","year":"2011","journal-title":"Acta Paediatr"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"e1575","DOI":"10.1542\/peds.2013-3060","article-title":"Adverse drug event-related emergency department visits associated with complex chronic conditions","volume":"133","author":"JA Feinstein","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"e0152208","DOI":"10.1371\/journal.pone.0152208","article-title":"Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997\u20132012","volume":"11","author":"A Doucette","year":"2016","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1047951116000470","article-title":"Respiratory syncytial virus hospitalisation trends in children with haemodynamically significant heart disease, 1997\u20132012","author":"PY Chu","year":"2016","journal-title":"Cardiol Young"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/0009922815604598","article-title":"Perceived Risk of Severe Respiratory Syncytial Virus Disease and Immunoprophylaxis Use Among US Pediatric Specialists","volume":"55","author":"DM Friedman","year":"2016","journal-title":"Clin Pediatr (Phila)"},{"key":"ref43","unstructured":"Agency for Healthcare Research and Quality. Measures of Pediatric Health Care Quality Based on Hospital Administrative Data: The Pediatric Quality Indicators 2006 [cited 2016 March 14]. Available from: http:\/\/www.qualityindicators.ahrq.gov\/Downloads\/Modules\/PDI\/V30\/pdi_measures_v30b.pdf<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0172512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T03:38:01Z","timestamp":1568864281000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0172512"}},"subtitle":[],"editor":[{"given":"Yu Ru","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0172512","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]}}}